Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 05, 2025

Get In Touch

Sunscreen That Includes Zinc Oxide Loses Effectiveness, Becomes Toxic After Two Hours: Study Dermatology

Sunscreen That Includes Zinc Oxide Loses Effectiveness, Becomes Toxic After Two Hours: Study

  • 27 July 2025
  • 3 months ago

Abrocitinib Bests Dupilumab For Treating Moderate-To-Severe Atopic Dermatitis: Lancet Dermatology

Abrocitinib Bests Dupilumab For Treating Moderate-To-Severe Atopic Dermatitis: Lancet

  • 27 July 2025
  • 3 months ago

Herbal Remedies And Complementary Medicine May Benefit Chronic Pruritus Patients: Study Dermatology

Herbal Remedies And Complementary Medicine May Benefit Chronic Pruritus Patients: Study

  • 27 July 2025
  • 3 months ago

Psoriasis Patients Are At Increased Risk Of Severe And Uncommon Infections, Says Study Dermatology

Psoriasis Patients Are At Increased Risk Of Severe And Uncommon Infections, Says Study

  • 27 July 2025
  • 3 months ago

Severe Atopic Eczema Patients May Have Increased Risk Of Death From Respiratory Diseases Dermatology

Severe Atopic Eczema Patients May Have Increased Risk Of Death From Respiratory Diseases

  • 27 July 2025
  • 3 months ago

Family History A Risk Factor For Development Of Melanoma Among Pediatric Population Dermatology

Family History A Risk Factor For Development Of Melanoma Among Pediatric Population

  • 27 July 2025
  • 3 months ago

Ixekizumab Safe To Use In Pediatric Patients With Moderate To Severe Plaque Psoriasis: JAMA Pediatrics and Neonatology

Ixekizumab Safe To Use In Pediatric Patients With Moderate To Severe Plaque Psoriasis: JAMA

  • 27 July 2025
  • 3 months ago

Cadila Pharma Launches Arthritis Biosimilar Drug Cadalimab In India Medicine

Cadila Pharma Launches Arthritis Biosimilar Drug Cadalimab In India

  • 27 July 2025
  • 3 months ago

Strict Avoidance Of Systemic Steroids Not Necessary In Psoriasis Patients: JAMA Dermatology

Strict Avoidance Of Systemic Steroids Not Necessary In Psoriasis Patients: JAMA

  • 26 July 2025
  • 3 months ago

Single-Dose Rifapentine May Prevent Leprosy Spread In Household Contacts: NEJM Dermatology

Single-Dose Rifapentine May Prevent Leprosy Spread In Household Contacts: NEJM

  • 26 July 2025
  • 3 months ago

Recent News

HC pulls up NMC for not filing reply in FMG Intern...

  • 04 November, 2025

Eli Lilly plans to build new USD 3 billion facilit...

  • 04 November, 2025

Rajkot Maternity Hospital CCTV Leak: How a simple...

  • 04 November, 2025

Gland Pharma profit rises 12 percent to Rs 184 cro...

  • 04 November, 2025

AIIMS Delhi doctors told to use Hindi in prescript...

  • 04 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.